Takeda Pharmaceutical
TAK
#476
Rank
$39.92 B
Marketcap
$12.60
Share price
-0.08%
Change (1 day)
-21.69%
Change (1 year)

Takeda Pharmaceutical (TAK) - P/B ratio

P/B ratio as of June 2024 : 0.8409

According to Takeda Pharmaceutical's latest financial reports the company has a price-to-book ratio of 0.8409.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Takeda Pharmaceutical - P/B ratio (from 2008 to 2023)

P/B ratio by year

Year P/B ratio Change
2023-12-310.9418-8.33%
2022-12-311.0311.47%
2021-12-310.9217-27.15%
2020-12-311.27-8.56%
2019-12-311.38-2.36%
2018-12-311.42-39.4%
2017-12-312.3425.64%
2016-12-311.86-15.57%
2015-12-312.2043.79%
2014-12-311.53-1.26%
2013-12-311.558.32%
2012-12-311.435.58%
2011-12-311.36-9.3%
2010-12-311.504.62%
2009-12-311.43-33.87%
2008-12-312.16

P/B ratio for similar companies or competitors

Company P/B ratio differencediff. Country
5.10 506.54%๐Ÿ‡บ๐Ÿ‡ธ USA
5.46 549.10%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
1.70 102.21%๐Ÿ‡บ๐Ÿ‡ธ USA
33.1 3,831.52%๐Ÿ‡บ๐Ÿ‡ธ USA
1.42 69.18%๐Ÿ‡ซ๐Ÿ‡ท France
8.12 866.11%๐Ÿ‡บ๐Ÿ‡ธ USA
4.96 489.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
16.9 1,912.23%๐Ÿ‡บ๐Ÿ‡ธ USA
3.71 341.76%๐Ÿ‡ฎ๐Ÿ‡ณ India